IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 25,250
-1,150 (-4.36%)
At close: Jun 5, 2026
IntoCell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,471 | 2,299 | 2,905 | 1,616 | - | 140.03 | |
Revenue Growth (YoY) | -15.82% | -20.86% | 79.72% | - | - | - |
Cost of Revenue | 4.66 | 8.12 | 13.59 | 5.4 | 4.92 | 4.17 |
Gross Profit | 2,466 | 2,291 | 2,891 | 1,611 | -4.92 | 135.86 |
Selling, General & Admin | 5,851 | 5,712 | 4,409 | 1,464 | 1,749 | 1,683 |
Research & Development | 6,252 | 6,076 | 7,561 | 17,198 | 7,354 | 3,182 |
Amortization of Goodwill & Intangibles | 240.19 | 240.19 | 83.92 | 0.9 | 1.85 | 6.28 |
Other Operating Expenses | 31.26 | 28.63 | 26.79 | 46.22 | 12.12 | 12.02 |
Operating Expenses | 12,889 | 12,591 | 12,682 | 19,001 | 9,456 | 5,214 |
Operating Income | -10,422 | -10,300 | -9,790 | -17,390 | -9,461 | -5,078 |
Interest Expense | -273.85 | -258.18 | -314.74 | -61.08 | -3.07 | -675.48 |
Interest & Investment Income | 859.06 | 767.04 | 574.83 | 672.57 | 805.39 | 433.63 |
Currency Exchange Gain (Loss) | -22.2 | -41.84 | -399.88 | -56.85 | -22.76 | 2.5 |
Other Non Operating Income (Expenses) | -1,099 | -485.13 | 4.29 | 27.68 | 32.18 | -2,026 |
EBT Excluding Unusual Items | -10,958 | -10,319 | -9,926 | -16,807 | -8,649 | -7,343 |
Gain (Loss) on Sale of Investments | -2.8 | -2.82 | 12.84 | 63.46 | -17.33 | 11.67 |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | - | - | - | - |
Asset Writedown | -282.12 | -282.12 | - | -31.58 | - | - |
Pretax Income | -11,243 | -10,603 | -9,913 | -16,775 | -8,667 | -7,331 |
Net Income | -11,243 | -10,603 | -9,913 | -16,775 | -8,667 | -7,331 |
Net Income to Common | -11,243 | -10,603 | -9,913 | -16,775 | -8,667 | -7,331 |
Shares Outstanding (Basic) | 15 | 14 | 13 | 13 | 13 | 11 |
Shares Outstanding (Diluted) | 15 | 14 | 13 | 13 | 13 | 11 |
Shares Change (YoY) | 11.53% | 8.69% | 1.07% | -0.00% | 15.73% | 86.09% |
EPS (Basic) | -765.42 | -744.02 | -756.00 | -1293.00 | -668.00 | -654.00 |
EPS (Diluted) | -765.42 | -744.02 | -756.00 | -1293.00 | -668.00 | -654.00 |
Free Cash Flow | -10,083 | -8,770 | -7,117 | -17,007 | -6,436 | -4,168 |
Free Cash Flow Per Share | -686.46 | -615.36 | -542.77 | -1310.88 | -496.10 | -371.79 |
Gross Margin | 99.81% | 99.65% | 99.53% | 99.67% | - | 97.02% |
Operating Margin | -421.76% | -448.01% | -337.01% | -1075.82% | - | -3626.12% |
Profit Margin | -454.99% | -461.20% | -341.23% | -1037.82% | - | -5235.49% |
Free Cash Flow Margin | -408.05% | -381.44% | -244.99% | -1052.17% | - | -2976.28% |
EBITDA | -9,637 | -9,526 | -9,105 | -16,547 | -8,685 | -4,432 |
D&A For EBITDA | 784.85 | 774.67 | 684.79 | 842.83 | 776.07 | 646.08 |
EBIT | -10,422 | -10,300 | -9,790 | -17,390 | -9,461 | -5,078 |